Magnite's Q2 2025 earnings showcase strong CTV and DV+ growth, key streamer partnerships, and AI advancements.

Today’s Forbes Daily newsletter covers Trump’s Fed chair candidates, Palantir’s rising share price, RFK cancels vaccine funding, GOP pushes for more on Epstein and more.

Discover how Vertex Pharmaceuticals achieved 12% Q2 2025 revenue growth with new launches like ALYFTREK, CASGEVY, & JOURNAVX.

(Reuters) -Figma shares surged nearly 158% in their market debut on Thursday, valuing the design software maker at about $50 ...

Trump announces new tariffs on countries that haven't made deals with U.S. as stock market dips. Bureau of Labor Statistics ...